Gemtesa and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Gemtesa (vibegron), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Urinary incontinence.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Gemtesa. It is created by eHealthMe based on reports of 2,622 people who have side effects when taking Gemtesa from the FDA, and is updated regularly.

What is Gemtesa?

Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,582 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 08, 2026

2,622 people reported to have side effects when taking Gemtesa.
Among them, 12 people (0.46%) have Appetite - decreased.

Could Gemtesa cause Appetite - decreased?

Among these 12 people:

How long have people been on Gemtesa when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Gemtesa? *

female: 75 %
male: 25 %

What is the age of people who have Appetite - decreased when taking Gemtesa? *

What are other drugs people take besides Gemtesa? *

Eliquis: 3 people, 25.00%
Xyrem: 2 people, 16.67%
Nurtec Odt: 2 people, 16.67%
Carbidopa, Levodopa And Entacapone: 2 people, 16.67%
Clonazepam: 2 people, 16.67%
Duopa: 2 people, 16.67%
Fioricet: 2 people, 16.67%
Fludrocortisone Acetate: 2 people, 16.67%
Myrbetriq: 2 people, 16.67%
Nuplazid: 2 people, 16.67%

What are other side effects people have besides Appetite - decreased? *

Urinary Tract Infection: 4 people, 33.33%
Abdominal Pain Upper: 3 people, 25.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 25.00%
Weight Decreased: 2 people, 16.67%
Product Taste Abnormal: 2 people, 16.67%
Depression: 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%
Overdose: 2 people, 16.67%
Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 16.67%

What are the existing conditions these people have? *

Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
Migraine (headache): 2 people, 16.67%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 16.67%
Drowsiness: 2 people, 16.67%
Delusion (a false belief or opinion): 2 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 8.33%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gemtesa and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemtesa:

Gemtesa (2,648 reports)

Browse all side effects of Gemtesa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,582 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vibegron (the active ingredients of Gemtesa) and Gemtesa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.